{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:51:23Z","timestamp":1785898283210,"version":"3.56.0"},"reference-count":45,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["17391"],"award-info":[{"award-number":["17391"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003980","name":"Istituto Toscano Tumori","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003056","name":"Ente Cassa di Risparmio di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cryoglobulinaemic vasculitis (CV) is a lymphoproliferative disorder related to hepatitis C virus (<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>) infection; anti\u2010viral therapy is the first therapeutic option. <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content> can be incapacitating, compromising the patients\u2019 quality of life (QoL). In a controlled study, interferon\u2010based therapy was associated with a lower virological response in vasculitic patients than in patients without vasculitis. Limited, uncontrolled data on direct\u2010acting anti\u2010virals are available.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To evaluate safety, clinical efficacy, virological response and the impact of interferon\u2010free treatment on QoL in HCV patients with and without mixed cryoglobulinaemia (MC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We prospectively studied <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content> patients with cryoglobulinaemia (with vasculitis\u2010CV\u2010 and without vasculitis\u2010<jats:styled-content style=\"fixed-case\">MC<\/jats:styled-content>\u2010) and without cryoglobulinaemia (controls), treated with direct\u2010acting anti\u2010virals. Hepato\u2010virological parameters, <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content> clinical response and impact on QoL were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred and eighty\u2010two <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content> patients were recruited (85 with <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>, 54 with <jats:styled-content style=\"fixed-case\">MC<\/jats:styled-content> and 43 controls). A sustained virological response at 12 weeks (<jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content>12) was achieved in 166 (91.2%) patients (77\/85 <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>, 48\/54 <jats:styled-content style=\"fixed-case\">MC<\/jats:styled-content>, 41\/43 controls). In <jats:styled-content style=\"fixed-case\">CV SVR<\/jats:styled-content> patients, cryocrit levels progressively decreased and clinical response progressively improved, reaching 96.7%, 24 weeks after treatment. QoL, baseline physical and mental component summaries were lower in the <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content> group compared to the other groups (<jats:italic>P<\/jats:italic> &lt; 0.05). Scores improved in all groups, and significantly in <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content> patients after <jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>No significant differences in <jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content> rates were recorded between cryoglobulinaemic patients and controls and a high clinical and immunological efficacy was confirmed in <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>, supporting the role of interferon\u2010free therapy as the first therapeutic option. Interestingly, <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content> patients had worse baseline QoL than other <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010positive groups and interferon\u2010free therapy was effective in significantly increasing QoL, suggesting the important role of direct\u2010acting anti\u2010viral\u2010based therapy in improving <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>'s individual and social burden.<\/jats:p><\/jats:sec>","DOI":"10.1111\/apt.14845","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T07:29:24Z","timestamp":1530170964000},"page":"440-450","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Interferon\u2010free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis"],"prefix":"10.1111","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6800-9149","authenticated-orcid":false,"given":"L.","family":"Gragnani","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cerretelli","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lorini","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Steidl","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Giovannelli","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Monti","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Petraccia","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sadalla","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Urraro","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Caini","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Xheka","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Simone","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Arena","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Matucci\u2010Cerinic","sequence":"additional","affiliation":[{"name":"Division of Rheumatology Department of Geriatric Medicine Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vergani","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies King's College Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Laffi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-4166","authenticated-orcid":false,"given":"A. L.","family":"Zignego","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine and Department of Oncology Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses (MASVE) Azienda Ospedaliero\u2010Universitaria Careggi (AOUC) Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-012-0825-6"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.03.004"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.018"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.997214"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.006"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v8.i2.107"},{"key":"e_1_2_7_8_1","first-page":"115","article-title":"Cryoglobulinaemias: a multi\u2010centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinemias","volume":"88","author":"Monti G","year":"1995","journal-title":"QJM"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60242-0"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.08.035"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.02.017"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-016-0410-9"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.01.008"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27623"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.02.010"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22168"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27826"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.029"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28446"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28297"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208339"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666160208145432"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28753"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.09.158"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.49"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1280-6"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9708-x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.09.025"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.04.003"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.006"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.07.005"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.1.4"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-253948"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.150755"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu271"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.05.013"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6901.449"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199303000-00006"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.03.006"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12879"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2015.1021660"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.039"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12625"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13490"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.14845","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.14845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T23:15:43Z","timestamp":1694387743000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.14845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1111\/apt.14845"],"URL":"https:\/\/doi.org\/10.1111\/apt.14845","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,28]]},"assertion":[{"value":"2018-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}